[Event Report] Joint Congress on Global Health 2023 Symposium “AMR as a Global Health Challenge” (64th Japanese Society of Tropical Medicine Conference, 38th Japanese Society of Global Health Conference, 27th Japanese Society of Travel Medicine Conference, 8th International Clinical Medicine Conference, November 24, 2023, Bunkyo City, Tokyo)
date : 12/8/2023
Tags: AMR
On November 24, Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno presented at the symposium “AMR as a Global Health Challenge” at the Joint Congress on Global Health held in Bunkyo-ku, Tokyo, Japan.
The Joint Congress on Global Health 2023 was organized by the 64th Annual Meeting of the Japanese Society for Tropical Medicine, the 38th Annual Meeting of the Japanese Society for International Health and Medicine, the 27th Annual Meeting of the Japanese Society of Travel Medicine, and the 8th Annual Meeting of the International Society of Clinical Medicine under the theme “Towards a Sea of Global Health – Inclusive of Diversity and Richness”. This is the third congress following those in 2017 and 2020.
The presentation titled “AMR as a Global Health Challenge,” addressed the role of antibiotics in non-communicable diseases and the three major infectious diseases (i.e. HIV/AIDS, tuberculosis and malaria), the increase in foreign-type resistant bacteria, the innovation needed for antimicrobial drug development, and the importance of international collaboration and multi-stakeholder cooperation in AMR control.
Symposium “AMR as Global Health Challenge”
■Chair:
Hiroshi Yotsuyanagi (Director, IMUST Hospital, Institute of Medical Science, University of Tokyo)
■Speakers:
Lecture 1 “AMR as a Global Health Challenge”
Yui Kohno (Manager, Health and Global Policy Institute)
Lecture 2 “The Japanese Government’s Response to AMR – From a Global Health Perspective”
Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Lecture 3 “Efforts by the pharmaceutical industry to combat AMR”
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)

Top Research & Recommendations Posts
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)



